Qualigen Therapeutics Inc (QLGN) stock has fallen -64.13% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives QLGN stock a score of 4 out of a possible 100.
That rank is chiefly influenced by a fundamental score of 0. QLGN stock has a mean target price of $9.00. This means analysts expect the stock to add 696.46% over the next 12 months. QLGN's rank also includes a long-term technical score of 4. The short-term technical score for QLGN is 10.
QLGN has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on QLGN!
Qualigen Therapeutics Inc (QLGN) stock has gained 5.61% while the S&P 500 is up 0.08% as of 11:39 AM on Monday, Jan 3. QLGN is up $0.06 from the previous closing price of $1.07 on volume of 892,868 shares. Over the past year the S&P 500 is up 28.90% while QLGN has fallen -64.13%. QLGN lost -$0.15 per share in the over the last 12 months.
Click Here to get the full Stock Report for Qualigen Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
